1800 202 8726
Thyroid biopsy results

Repeat Thyroid FNAC — After a Non-Diagnostic Result

A non-diagnostic report after your thyroid biopsy does not mean something is wrong with the nodule. It means the sample collected did not contain enough cells for the laboratory to assess. A repeat biopsy, done with ultrasound guidance, resolves this in most cases.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

  • It is a sample quality issue — Non-diagnostic means the first sample was insufficient, not that the nodule is concerning.
  • It happens regularly — Non-diagnostic is one of the most common thyroid FNAC outcomes, across all settings.
  • Ultrasound guidance helps — Repeating with real-time ultrasound guidance substantially reduces the chance of a second non-diagnostic result.
  • Most repeats give a clear answer — The majority of patients who need a repeat biopsy receive a reportable Bethesda category from the second sample.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

A non-diagnostic thyroid FNAC result is common and does not mean your nodule is dangerous. It means the first sample did not contain enough cells to report. The American Thyroid Association recommends a repeat FNAC performed under ultrasound guidance. Most repeat biopsies yield a clear result.

How often does a thyroid FNAC come back non-diagnostic?

A non-diagnostic result is one of the most common thyroid FNAC outcomes, and it occurs even in experienced centres with well-prepared samples. It does not mean the clinician made an error or that something was missed.

The Bethesda System for Reporting Thyroid Cytopathology — the international standard used by most pathology laboratories — assigns non-diagnostic its own category, Bethesda I. This category exists precisely because the result says nothing about whether cancer is or is not present. It says only that the sample was insufficient.

Most nodules that produce a non-diagnostic result on first biopsy are benign. The non-diagnostic label is about the sample, not the nodule.

Does ultrasound guidance make a repeat biopsy more likely to succeed?

Yes. Real-time ultrasound guidance allows the clinician to see the needle position as it moves and to direct it into the most cellular part of the nodule. This is especially important for nodules that are partly fluid-filled or positioned awkwardly.

Rapid on-site evaluation — where a cytopathologist checks the sample in the procedure room before you leave — adds a further layer. It tells the clinician whether the material collected is adequate, while there is still an opportunity to take an additional pass if it is not.

American Thyroid Association guidance and published evidence both support repeating with ultrasound guidance rather than free-hand. The combination of imaging guidance and on-site adequacy assessment substantially reduces the rate of a second non-diagnostic result.

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

What do the words on your report mean?

Non-diagnostic / Unsatisfactory
The sample did not contain enough thyroid follicular cells for the laboratory to give a result. It says nothing about whether cancer is present or absent.
Bethesda Category I
The formal classification for a non-diagnostic result in the Bethesda System for Reporting Thyroid Cytopathology, used by most laboratories in India and internationally.
Cystic nodule
A nodule that contains fluid. Fluid yields very few cells on biopsy, which is one of the most common reasons a first sample comes back non-diagnostic.
On-site adequacy assessment (ROSE)
Rapid on-site evaluation — a cytopathologist reviews the slide in the procedure room while the biopsy is still in progress, confirming whether the sample is sufficient before you leave.
Follicular cells
The thyroid cells the laboratory needs to see in order to assign a Bethesda category. A sample without enough of these cannot be classified.

What happens at your repeat FNAC appointment

  1. Timing is arranged

    Your oncologist or endocrinologist schedules the repeat after a waiting period of at least several weeks, to allow any minor tissue reaction from the first procedure to settle before the sample area is re-entered.

  2. Ultrasound review before the needle

    The clinician examines your thyroid on ultrasound to identify the target area, check whether the nodule has changed, and plan the needle approach for the best sampling angle.

  3. Guided biopsy

    The FNAC is performed under real-time ultrasound. The clinician makes multiple passes through the nodule to maximise the cells collected, watching the needle position throughout.

  4. On-site adequacy check

    Where a cytopathologist is available in the room, the slide is reviewed immediately. If the sample is insufficient, a further pass can be taken before the procedure ends.

  5. Result and next step

    The sample is processed in the laboratory and assigned a Bethesda category, typically within a few days to a week. Your team will discuss the result and what it means for your care.

Explore 133 more Biopsy by Body Part topics

HUB — Biopsy by Body Part

All Biopsy by Body Part →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

How soon should I repeat the biopsy?

Your team will advise waiting at least several weeks before repeating. This is not a delay for its own sake — it lets any minor tissue reaction from the first needle settle, so the sample area is in its normal state when the repeat is done. The American Thyroid Association recommends repeating with ultrasound guidance rather than going back immediately without imaging. If your nodule has features that need closer watching, your team may adjust the timing accordingly.

What if the second biopsy is also non-diagnostic?

A second non-diagnostic result narrows your options. Your endocrinologist or oncologist will typically discuss either a diagnostic surgical procedure or careful monitoring with ultrasound, depending on the nodule's size, its ultrasound characteristics, and your overall health. A second non-diagnostic result does not confirm cancer — it means the biopsy route alone has not been able to give an answer, and a different approach is needed to get one.

Why was my first biopsy non-diagnostic?

The most common reasons are a nodule that is mostly fluid-filled rather than solid, a small or awkwardly placed nodule, and sampling without real-time ultrasound guidance. These are technical factors, not a sign that the nodule is more serious. The repeat biopsy, performed under ultrasound guidance, is designed specifically to address them. Most people who have a non-diagnostic first result receive a clear answer from the second.

Does a non-diagnostic result mean the nodule is likely to be cancer?

No. The Bethesda System places non-diagnostic in its own category because the result cannot say anything about whether cancer is present or absent — it records only that the sample was insufficient. The vast majority of thyroid nodules, including those that require a repeat biopsy, turn out to be benign. Your oncologist will help you understand your nodule's standing based on its ultrasound features alongside the biopsy result.

Will the repeat biopsy be more uncomfortable than the first?

The procedure is the same as the first. Most people find a thyroid FNAC causes mild discomfort rather than significant pain, and that level does not increase with repeat procedures. Local anaesthetic is applied to the skin before the needle is inserted. If you found the first procedure more uncomfortable than you expected, tell your team beforehand so they can take extra care with positioning and technique.

Can a scan replace a repeat biopsy?

No. Ultrasound, CT, and PET-CT scans show the size, shape, and vascularity of a thyroid nodule, but they cannot determine whether individual cells are benign or malignant. A non-diagnostic biopsy needs a repeat biopsy to get that cellular information. Scans and biopsies answer different questions — a more advanced scan does not substitute for a repeat FNAC when the pathology has not yet been established.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation